Skip to main content
. 2024 Mar 5;6(2):dlae027. doi: 10.1093/jacamr/dlae027

Figure 5.

Figure 5.

Resistance profiles for enterococci from healthy communities in Lusaka and Ndola districts. AMP, ampicillin; CHL, chloramphenicol; CIP, ciprofloxacin; ERY, erythromycin; LZD, linezolid; NIT, nitrofurantoin, PEN, penicillin, Q/D, quinupristin/dalfopristin; TE, tetracycline; VAN, vancomycin.